Síndrome neuroléptico maligno y poliserositis en paciente usuaria de clozapina: una asociación infrecuente

Malignant neuroleptic syndrome is a complication of antipsychotic medication use. Clozapine use is also associated with polyserositis and eosinophilia. We report a 17 years old female treated with clozapine, valproic acid, lithium carbonate and lorazepam that consulted in the emergency room for conf...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Eymin L,Gonzalo, Andresen H,Max, Godoy F,Jaime, Rada G,Gabriel
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2005
Materias:	Bromocriptine Clozapine Neuroleptic malignant syndrome neuroleptic-induced
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005001000012
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872005001000012
record_format	dspace
spelling	oai:scielo:S0034-988720050010000122005-12-05Síndrome neuroléptico maligno y poliserositis en paciente usuaria de clozapina: una asociación infrecuenteEymin L,GonzaloAndresen H,MaxGodoy F,JaimeRada G,Gabriel Bromocriptine Clozapine Neuroleptic malignant syndrome neuroleptic-induced Malignant neuroleptic syndrome is a complication of antipsychotic medication use. Clozapine use is also associated with polyserositis and eosinophilia. We report a 17 years old female treated with clozapine, valproic acid, lithium carbonate and lorazepam that consulted in the emergency room for confusion, lethargy, catatonia, rigidity, myalgya and fever. Complete blood count showed eosinophilia. An abdominal CAT scan showed ascites and pleural effusion. Clozapine was discontinued and bromocriptine was started. One week after admission, the patient remained febrile and liver enzymes were elevated. Valproic acid was discontinued. Inflammatory parameters stated to subside and the patient was discharged afebrile days after admission (Rev Méd Chile 2005; 133: 1225-8)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.133 n.10 20052005-10-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005001000012es10.4067/S0034-98872005001000012
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Bromocriptine Clozapine Neuroleptic malignant syndrome neuroleptic-induced
spellingShingle	Bromocriptine Clozapine Neuroleptic malignant syndrome neuroleptic-induced Eymin L,Gonzalo Andresen H,Max Godoy F,Jaime Rada G,Gabriel Síndrome neuroléptico maligno y poliserositis en paciente usuaria de clozapina: una asociación infrecuente
description	Malignant neuroleptic syndrome is a complication of antipsychotic medication use. Clozapine use is also associated with polyserositis and eosinophilia. We report a 17 years old female treated with clozapine, valproic acid, lithium carbonate and lorazepam that consulted in the emergency room for confusion, lethargy, catatonia, rigidity, myalgya and fever. Complete blood count showed eosinophilia. An abdominal CAT scan showed ascites and pleural effusion. Clozapine was discontinued and bromocriptine was started. One week after admission, the patient remained febrile and liver enzymes were elevated. Valproic acid was discontinued. Inflammatory parameters stated to subside and the patient was discharged afebrile days after admission (Rev Méd Chile 2005; 133: 1225-8)
author	Eymin L,Gonzalo Andresen H,Max Godoy F,Jaime Rada G,Gabriel
author_facet	Eymin L,Gonzalo Andresen H,Max Godoy F,Jaime Rada G,Gabriel
author_sort	Eymin L,Gonzalo
title	Síndrome neuroléptico maligno y poliserositis en paciente usuaria de clozapina: una asociación infrecuente
title_short	Síndrome neuroléptico maligno y poliserositis en paciente usuaria de clozapina: una asociación infrecuente
title_full	Síndrome neuroléptico maligno y poliserositis en paciente usuaria de clozapina: una asociación infrecuente
title_fullStr	Síndrome neuroléptico maligno y poliserositis en paciente usuaria de clozapina: una asociación infrecuente
title_full_unstemmed	Síndrome neuroléptico maligno y poliserositis en paciente usuaria de clozapina: una asociación infrecuente
title_sort	síndrome neuroléptico maligno y poliserositis en paciente usuaria de clozapina: una asociación infrecuente
publisher	Sociedad Médica de Santiago
publishDate	2005
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005001000012
work_keys_str_mv	AT eyminlgonzalo sindromeneurolepticomalignoypoliserositisenpacienteusuariadeclozapinaunaasociacioninfrecuente AT andresenhmax sindromeneurolepticomalignoypoliserositisenpacienteusuariadeclozapinaunaasociacioninfrecuente AT godoyfjaime sindromeneurolepticomalignoypoliserositisenpacienteusuariadeclozapinaunaasociacioninfrecuente AT radaggabriel sindromeneurolepticomalignoypoliserositisenpacienteusuariadeclozapinaunaasociacioninfrecuente
_version_	1718436229113970688

Síndrome neuroléptico maligno y poliserositis en paciente usuaria de clozapina: una asociación infrecuente

Ejemplares similares